NCT00059592View on ClinicalTrials.gov

Valacyclovir in Immunocompromised Children

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

April 7, 1998

Primary Completion Date

December 30, 2004

Study Completion Date

May 5, 2005

Conditions
ShinglesBone Marrow Transplantation
Interventions
DRUG

Valacyclovir

Trial Locations (2)

19104

Children's Hospital of Philadelphia, Philadelphia

77030

Texas Children's Hospital, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER

NCT00059592 - Valacyclovir in Immunocompromised Children | Biotech Hunter | Biotech Hunter